National Association of Testing Authorities, Australia
Scope of Accreditation
Alfred Pathology Service
Site
Alfred Hospital
Accreditation No.
2349
Site No.
2342
Date of Accreditation
08 Apr 1988
Contact
Ms Jodie Wright P: +61 (03) 90763888
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Alfred Centre theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Sulfhaemoglobin; pH |
Anatomical Pathology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Ocular specimens; Other body fluids; Sputum; Urine; Vitreous specimens; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Nipple discharge | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin fluorescence in situ hybridisation (FISH) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue; Smears; Tissue imprint | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Fresh tissue; Frozen tissue | Detection of antigenic targets - Various | |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Detection of antigenic targets - Various | ||
| Fresh tissue; Frozen tissueSkeletal muscle | Detection of antigenic targets - Various | |
| Anatomical pathology - Tissue pathology - Skeletal muscle enzyme histochemistry | Frozen sections of skeletal muscle | Detection of muscle enzyme targets |
Catheter Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Sulfhaemoglobin; pH |
Clinical Biochemistry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Calculi | Ammonium; Apatite; Bilirubin; Brushite; Calcium; Calcium oxalate dihydrate (weddelite); Calcium oxalate monohydrate; Carbonate; Cholesterol; Cysteine; Cystine; Hydrated calcium oxalate (whewellite); Hydroxylapatite (hydroxyapatite); Magnesium; Oxalate; Phosphate; Silicon; Sulfate; Triple phosphate - Struvite; Urate; Uric acid; Whitlockite; Xanthine |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Thiocyanate |
| Ethanol | ||
| Urine | Cocaine metabolites | |
| Amphetamines; Barbiturates; Benzodiazepines; Cannabinoids; Cocaine; Ethanol; Opiates | ||
| Amphetamines; Benzodiazepines; Cannabinoids; Opiates | ||
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Everolimus; Sirolimus; Tacrolimus |
| Plasma | Gabapentin; Lacosamide; Lamotrigine; Levetiracetam; Mycophenolic acid; Oxcarbamazepine; Perampanel | |
| Aripiprazole; Clozapine; Dehydro aripiperazole; Fluconazole; Haloperidol; Hydroxyitraconazole; Isavuconazole; Itraconazole; Linezolid; Norclozapine; Norquetiapine; Olanzapine; Paliperidone; Posaconazole; Quetiapine; Risperidone; Voriconazole | ||
| Amikacin; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Paracetamol (acetaminophen); Phenytoin (dilantin); Salicylate; Tobramycin; Tricyclics; Valproate (valproic acid, epilim); Vancomycin | ||
| Carbamazepine; Methotrexate | ||
| Plasma; Serum | Thiopentone | |
| Cefazolin; Cefepime; Meropenem; Piperacillin; Tazobactam | ||
| Urine | Cotinine | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma | Anti-thyroglobulin; Thyroglobulin |
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); α-Fetoprotein (AFP); β2-Microglobulin (B2M) | ||
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Adrenocorticotropic hormone (ACTH); Parathyroid hormone (PTH) |
| Insulin | ||
| C-peptide; Cortisol; Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone - Free; Testosterone - Total | ||
| Aldosterone; Fibroblast growth factor 23 (FGF23); Insulin-like growth factor 1 (IGF-1, somatomedin C); Renin | ||
| Urine | Cortisol | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests)part of nsv | Plasma | Dehydroepiandrosterone sulfate (DHEAS); Growth hormone |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Plasma | B-type natriuretic peptide (BNP); Creatine kinase MB (CKMB); N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin I |
| Troponin T | ||
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma | Caeruloplasmin; α1-Antitrypsin |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Plasma | Haptoglobins | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid; Peritoneal fluid | Albumin; Amylase; Glucose; Lactate dehydrogenase (LDH); Protein - Total |
| Cerebrospinal fluid (CSF) | Glucose; Protein - Total | |
| Lactate; Lactate dehydrogenase (LDH) | ||
| Peritoneal dialysis fluid | Creatinine; Glucose; Lactate dehydrogenase (LDH); Urea | |
| Plasma | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Angiotensin converting enzyme (ACE); Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - HDL; Cholesterol - LDL; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Cystatin C | ||
| Pleural fluid | Albumin; Cholesterol - Total; Glucose; Lactate dehydrogenase (LDH); Protein - Total; Triglycerides | |
| pH | ||
| Serum; Urine | Osmolality | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Glucose; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Plasma; Serum | Folate |
| Chemical pathology - Iron studies | Plasma | Ferritin; Iron; Transferrin |
| Chemical pathology - Markers of bone metabolism | Plasma | Procollagen type 1 N-terminal propeptide (P1NP); c-Telopeptide (CTx) |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Sulfhaemoglobin; pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Homocysteine; β-Hydroxybutyrate |
| Chemical pathology - Quantitation of vitamin B markers | Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Plasma | Cobalamin (vitamin B12) |
| Plasma; Serum | Ascorbic acid (vitamin C); Retinol (vitamin A); Tocopherol (vitamin E) | |
| Serum | 25-Hydroxyvitamin D; Cobalamin (vitamin B12) | |
| Chemical pathology - Tests for thyroid function | Plasma | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Blood | Cadmium; Lead; Manganese; Mercury; Thallium |
| Plasma | Aluminium; Chromium; Cobalt; Copper; Manganese; Selenium; Zinc | |
| Urine | Aluminium; Arsenic; Cadmium; Chromium; Cobalt; Copper; Iodine; Iron; Lead; Manganese; Mercury; Nickel; Selenium; Thallium; Vanadium; Zinc | |
| Haematology - Diagnosis of thalassemia | Blood | Examination of haemoglobin H (HbH); Haemoglobin A2 (HbA2) - Quantitation |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma | Anti-thyroid peroxidase antibodies (TPO); Anti-thyrotropin receptor antibodies (TSHR) |
| Rheumatoid factor | ||
| Anti-cyclic citrullinated peptide antibodies (CCP) | ||
| Serum | Anti-neutrophil cytoplasmic antibodies (ANCA) | |
| Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-smooth muscle antibodies (SMA) | ||
| Anti-nuclear antibodies (ANA) | ||
| Immunopathology - Quantitation of complement proteins | Plasma | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF) | Oligoclonal bands |
| Other body fluids | Asialo-transferrin; β-Trace protein (β-TP) | |
| Plasma | Cryofibrinogen; Cryoglobulins | |
| Serum | Anti-daratumumab | |
| Detection and amount of paraproteins; Protein classes | ||
| Serum; Urine | Detection and quantitation of free kappa and free lambda light chains; Detection of Bence Jones proteins | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Plasma; Serum | Immunoglobulin subclasses | |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Haematology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Snake bite site | Snake venom detection |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Asparaginase |
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Examination of blood films by special staining | Blood; Bone marrow | Haemoglobin H; Heinz bodies; Iron; Malaria |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Feto-maternal haemorrhage (FMH) estimation |
| Presence of foetal red blood cells | ||
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean platelet volume (MPV); Morphology; Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes |
| Differential number; Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Rivaroxaban |
| Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa activity; Anti-thrombin III; D-dimer; Emicizumab levels; Factor V; Factor VIII binding assay (vWF Normandy); Factor VIIIc inhibitor; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Protein C and protein S; Prothrombin time (PT); Reptilase time; Thrombin time (TT); Von Willebrand collagen binding assay; Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | ||
| Von Willebrand factor (vWF); Von Willebrand factor (vWF) multimers | ||
| Heparin induced thrombotic thrombocytopenia (HITT); Platelet aggregation | ||
| Factor VIII | ||
| Haematology - Investigation of haemolysis | Urine | Haemosiderin |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | CD16; CD19; CD2; CD4; CD45; CD56; CD8; Cytotoxic T-cells; Lymphocyte surface markers; Natural killer (NK) cells; T follicular helper cells |
| Blood; Bone marrow; Disaggregated tissues specimen; Fluids | Assessment of lymphoid cell populations; Assessment of myeloid cell populations | |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-extractable nuclear antigen antibodies (ENA) |
| Anti-cardiolipin antibodies (ACA); Anti-double stranded DNA antibodies (dsDNA); Anti-gliadin antibodies (AGA); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies; Tryptase | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Ampicilloyl group; Cefaclor; Chlorhexidine; Gelatin - Bovine; Insulin - Human; Morphine; Penicilloyl G; Penicilloyl V; Pholcodine; Suxamethonium (succinylcholine) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Caged bird mix; Cat epithelium; Cow dander; Dog dander; Feather mix; Ferret epithelium; Guinea pig epithelium; Horse dander; Mouse epithelium; Mouse serum proteins; Mouse urine proteins; Rabbit epithelium; Rabbit urine proteins; Rat epithelium; Rat serum proteins; Rat urine proteins |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [additives] allergens) | Serum | Cochineal extract (carmine red, E120) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg; Egg white; Egg yolk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Abalone; Anchovy; Blue mussel; Codfish; Crab; Eel; Fish mix; Haddock; Lobster; Mackerel; Octopus; Oyster; Pacific squid; Plaice; Red snapper; Salmon; Sardine (pilchard); Scallop; Shrimp; Swordfish; Trout; Tuna |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Apricot; Aubergine (eggplant); Avocado; Banana; Beetroot; Blueberry; Broccoli; Cabbage; Carrot; Cauliflower; Celery; Cherry; Cranberry; Cucumber; Fig; Garlic; Grape; Grapefruit; Kiwi; Lemon citrus; Lettuce; Lychee; Mandarin (tangerine, clementine, satsumas) citrus; Mango; Melon; Olive - Black, fresh; Onion; Orange citrus; Papaya; Passion fruit; Peach; Pear; Pineapple; Plum; Potato; Pumpkin; Raspberry; Spinach; Strawberry; Sweet potato; Tomato; Watermelon |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Galactose-α-1,3-galactose; Meat mix; Mutton; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Casein; Cheese - Cheddar type; Cheese - Mould type; Cow milk; Goat milk; Sheep milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Baker's yeast; Cacao; Chocolate; Honey; Malt; Mushroom; Omega-5-gliadin; Psyllium (ispaghula); Staple food mix; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Buck wheat; Cashew nut; Cereal mix; Chick pea; Coconut; Common millet; Gluten; Green bean; Hazelnut; Lentil; Lima bean; Linseed; Macadamia nut; Maize; Nut panel; Oat; Pea; Peanut; Pecan nut; Pinenut; Pistachio; Poppy seed; Rapeseed; Rice; Rye; Sesame seed; Soy bean; Sunflower seed; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens) | Serum | Allspice; Caraway; Chilli pepper; Cinnamon; Clove; Coriander (cilantro); Mint; Mustard; Nutmeg; Paprika (sweet pepper); Saffron; Spice mix; Vanilla |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Bermuda grass; Cocksfoot; Grass mix; Johnson grass; Perennial rye grass; Timothy grass; Velvet grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | Cockroach; Fire ant; Mosquito |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria tenius; Aspergillus fumigatus; Cladosporium herbarum; Penicillium chrysogenum (formerly Penicillium notatum); Trichophyton rubrum; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential miscellaneous allergens) | Serum | Seminal fluid; Tobacco leaf |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides pteronyssinus house dust mite; House dust mite mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Formaldehyde/formalin; Latex; Oxirane (ethyleneoxide); α-Amylase |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Australian pine; Cypress; Elm; Eucalyptus; Hazel; Melaleuca; Olive; Plane tree; Privet; Red cedar; Silver birch; Tree mix; Wattle |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; Honey bee venom; Jumper ant; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Common ragweed; Lupin; Plantain - English; Wall pellitory; Weed mix |
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells | Haemopoietic progenitor cellsMononuclear cells to be added to masterlist | Enumeration of CD34+ cells |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin E |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma | Infectious mononucleosis |
HITH
ISO 15189 (2022)
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Human Molecular Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Molecular genetics - DNA extraction | Blood; Bone marrow; Buccal swabs | Viable DNA for sequencing |
| Molecular genetics - DNA sequencing | Extracted DNA | Sequenced DNA utilising massively parallel sequencing technologies |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood; Bone marrow; Extracted DNA | Isocitrate dehydrogenase IDH1 and IDH2 mutation analysis; JAK2 V617F mutation |
| FLT3-ITD (internal tandem duplication) mutation; FLT3-TKD (tyrosine kinase domain) mutation; Nucleophosmin 1 (NPM1) mutation | ||
| Blood; Bone marrow; RNA; cDNA | FIP1L1-PDGFRA fusion transcripts; Isocitrate dehydrogenase IDH1 and IDH2 mutation analysis; Nucleophosmin 1 (NPM1) mutant transcripts | |
| Extracted DNA; Formalin-fixed paraffin-embedded (FFPE) tissues | BRAF mutation analysis; EGFR mutation analysis; KIT mutation analysis; KRAS mutation analysis; NRAS mutation analysis | |
| Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes | Blood; Bone marrow; Buccal swabs | Blood borne tumours; Mastocytosis; Myelodysplastic syndromes; Myeloproliferative neoplasms |
| Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
Immunohaematology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Investigation of haemolysis | Blood | Cold agglutinins; Direct antiglobulin test (DAT, direct Coombs test) |
| Immunohaematology - Blood group antibody detection | Blood | Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution; Antibody titration; Donath-Landsteiner antibody; Other blood group antibodies; Red blood cell phenotyping; Rh |
| Antibody elution | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Sulfhaemoglobin; pH |
Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Respiratory specimens; Sputum; Tissues; Urine | Pathogenic identification and antibiotic susceptibility |
| Bacteria; Pathogenic microorganisms | ||
| Aspirates; Fluids; General swabs; Respiratory specimens; Sputum; Tissues | Bacteria | |
| Blood | Pathogenic identification and antibiotic susceptibility | |
| Faeces | Clostridioides difficile toxin | |
| Fluids | Bacteria; Pathogenic microorganisms | |
| Fluids; Urine | Crystals | |
| Urine | Pathogenic identification and antibiotic susceptibility | |
| Legionella antigen; Streptococcus pneumoniae antigen | ||
| Bacteria; Casts; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Axilla swabs; Groin swabs; Nasal swabs; Rectal swabs | Candida auris; Carbapenemase-producing organisms (CPO); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) |
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Blood transfusion bags | Bacterial growth - Sterility |
| Dialysis waters; Environmental swabs; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | Van A/B |
| Bacterial isolates; Respiratory specimens | CarbaR; Respiratory pathogens | |
| Genital swabs; Rectal swabs; Throat swabs; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Malaria |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Respiratory specimens; Urine | Adenovirus; Cytomegalovirus (CMV); Enterovirus; Herpes simplex virus (HSV); Varicella zoster virus (VZV) |
| Bronchial washings; Bronchoalveolar lavage; Endotrachael aspirate; Nasal swabs; Nasopharyngeal swabs; Respiratory specimens; Sputum; Throat swabs | Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3; Respiratory syncytial virus (RSV) A/B; Rhinovirus | |
| Bronchoalveolar lavage | Cytomegalovirus (CMV) | |
| Bronchoalveolar lavage; Sputum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Plasma | Cytomegalovirus (CMV) | |
| Human immunodeficiency virus type 1 (HIV-1) RNA | ||
| Plasma; Serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA | |
| Sputum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols | Saliva | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Blood; Other body fluids; Respiratory specimens; Tissues | Mycobacteria detection; Mycobacteria identification |
| Mycobacteria detection; Mycobacteria identification | ||
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Aspirates; Cerebrospinal fluid (CSF); Fluids; General swabs; Sputum; Tissues; Urine | Fungi identification; Yeast susceptibility; Yeasts identification |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces; Skin scrapings; Urine | Cryptosporidia; Cysts; Ova; Parasites |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Cerebrospinal fluid (CSF); Serum | Cryptococcus spp. |
| Plasma | Cytomegalovirus (CMV) | |
| Serum | Cytomegalovirus (CMV); Epstein-Barr virus; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus antibody (anti-HCV) - IgG; Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen; Rubella IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody; Syphilis Treponema pallidum antibody; Toxoplasma | |
| Syphilis Treponema pallidum antibody | ||
| Streptococcal anti-DNAse B (anti-streptodornase) antibody | ||
| Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis C virus (HCV); Herpes simplex virus (HSV) IgG; Measles IgG antibody; Mumps virus IgG antibody; Mycoplasma pneumoniae IgG antibody; Mycoplasma pneumoniae IgM antibody; Varicella zoster virus (VZV) IgG antibody | ||
| Anti-streptolysin O (ASOT) |
Operating Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
11 Feb 2028
Last Activity Date
06 Aug 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Sulfhaemoglobin; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2349
Site No.
2342
Print date
15 Dec 2024
END OF SCOPE